Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,646.00+3.75%ETH$2,428.90+6.37%GOLD$4,071.90-0.03%OIL$88.17+0.06%
Smart Investors Daily
SID Premium
Coloplast A/S logo

OTC · CLPBY

Coloplast A/S

Healthcare · Medical - Instruments & Supplies

$7.93

Up+$0.55 (+7.45%)

Updated Nov 4, 2026, 11:48 PM

SID Score

5.5/10

Composite research score

Smart Money

46/100

Neutral

Market cap
19.84B
P/E ratio
31.03
Dividend yield
4.46%
52-week range
— – —
Volume
81.26K
Avg. volume
405.67K

Price performance · CLPBY

CLPBY price history

1M range · 0 trading sessions · Daily adjusted prices

CLPBY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CLPBY news

The latest Smart Investors Daily articles mentioning CLPBY.

Stock researchCompany · Overview

CLPBY research

Overview

Company profile and research snapshot.

Company profile

COLOPLAST AS SP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$14.45
Implied upside
—
Analysts
—
CLPBY recent ratings
DateFirmRatingTarget
Sep 23, 2026ROTHSCHILD & CO REDBURNNeutral—
Sep 23, 2026JEFFERIESBuy—
Sep 22, 2026JYSKE BANKBuy—
Sep 21, 2026BERENBERGHold—
Sep 10, 2026BAADER EUROPE / ALPHAVALUEBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 29, 2026

Coloplast opens new factory in Portugal to support global growth

Frank Berg Rasmussen Vice President of Portugal Manufacturing site Coloplast Coloplast's manufacturing site in Portugal Coloplast manufacturing site in Felgueiras Coloplast today inaugurates its largest manufacturing site to date, a two-floor 50,000 m2 facility in Felgueiras, Portugal, expanding the company’s production capacity to meet growing global demand for continence care products, while supporting the company’s long-term ambition of helping four million people worldwide. Our new manufactu

Yahoo · Oct 21, 2026

Coloplast A/S - FY 2025/26 Earnings Release - Invitation for conference call on 3 November 2026 at 11.00am CET

Tuesday, 3 November 2026 at 11.00 - 12.00am CETIn connection with the publication of Coloplast’s financial results for FY 2025/26, to be released same day around 07.30 am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event. Coloplas

Yahoo · Oct 18, 2026

Coloplast (CPSE:COLO B) Stock Could Be 47% Undervalued On Cash Flow

Coloplast has seen its share price fall a long way over the past few years, yet recent gains have nudged the stock higher again and put fresh focus on whether the current price lines up with the cash the business can generate. After such a mixed share price record, the key issue is whether the cash flow story supports where Coloplast trades today. The stock is down 48.6% over 5 years. This puts the spotlight squarely on whether the cash flows behind the business still justify the market...

Yahoo · Oct 1, 2026

Coloplast A/S - Major shareholder announcement

Major shareholder announcement Reference is made to the press release issued by Coloplast A/S on 4 September 2026 regarding the expected implementation of the generational change in the ultimate ownership of Coloplast A/S. Coloplast A/S hereby announces that on 1 October 2026, Coloplast A/S has received the following major shareholder notification: NPLH Holding ApS, a company 100% owned and controlled by Niels Peter Louis-Hansen, has transferred, by way of a gift, all its shares in Coloplast Hol

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By